FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2470099993> ?p ?o ?g. }

• W2470099993 endingPage "153" @default.
• W2470099993 startingPage "142" @default.
• W2470099993 abstract "Cisplatin (cis-diamminedichloroplatinum, CDDP) is one of the most effective chemotherapeutic drugs that are used for treatment of patients with gastrointestinal cancer cells, but its continuous administration often evokes the development of chemoresistance. In this study, we investigated alterations in antioxidant molecules and functions using a newly established CDDP-resistant variant of gastric cancer MKN45 cells, and found that aldo-keto reductase 1B10 (AKR1B10) is significantly up-regulated with acquisition of the CDDP resistance. In the nonresistant MKN45 cells, the sensitivity to cytotoxic effect of CDDP was decreased and increased by overexpression and silencing of AKR1B10, respectively. In addition, the AKR1B10 overexpression markedly suppressed accumulation and cytotoxicity of 4-hydroxy-2-nonenal that is produced during lipid peroxidation by CDDP treatment, suggesting that the enzyme acts as a crucial factor for facilitation of the CDDP resistance through inhibiting induction of oxidative stress by the drug. Transient exposure to CDDP and induction of the CDDP resistance decreased expression of peroxisome proliferator-activated receptor-γ (PPARγ) in MKN45 and colon cancer LoVo cells. Additionally, overexpression of PPARγ in the cells elevated the sensitivity to the CDDP toxicity, which was further augmented by concomitant treatment with a PPARγ ligand rosiglitazone. Intriguingly, overexpression of AKR1B10 in the cells resulted in a decrease in PPARγ expression, which was recovered by addition of an AKR1B10 inhibitor oleanolic acid, inferring that PPARγ is a downstream target of AKR1B10-dependent mechanism underlying the CDDP resistance. Combined treatment with the AKR1B10 inhibitor and PPARγ ligand elevated the CDDP sensitivity, which was almost the same level as that in the parental cells. These results suggest that combined treatment with the AKR1B10 inhibitor and PPARγ ligand is an effective adjuvant therapy for overcoming CDDP resistance of gastrointestinal cancer cells." @default.
• W2470099993 created "2016-07-22" @default.
• W2470099993 creator A5007615482 @default.
• W2470099993 creator A5008074177 @default.
• W2470099993 creator A5015424874 @default.
• W2470099993 creator A5023842343 @default.
• W2470099993 creator A5045918329 @default.
• W2470099993 creator A5048990516 @default.
• W2470099993 creator A5049966177 @default.
• W2470099993 creator A5066182280 @default.
• W2470099993 creator A5066258586 @default.
• W2470099993 creator A5068621397 @default.
• W2470099993 creator A5072962309 @default.
• W2470099993 date "2016-08-01" @default.
• W2470099993 modified "2023-09-23" @default.
• W2470099993 title "Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism" @default.
• W2470099993 cites W1821596905 @default.
• W2470099993 cites W1965090988 @default.
• W2470099993 cites W1965788245 @default.
• W2470099993 cites W1970161481 @default.
• W2470099993 cites W1979545982 @default.
• W2470099993 cites W1987604182 @default.
• W2470099993 cites W1987664323 @default.
• W2470099993 cites W1994637146 @default.
• W2470099993 cites W1994711032 @default.
• W2470099993 cites W1995302014 @default.
• W2470099993 cites W1997594582 @default.
• W2470099993 cites W2011645692 @default.
• W2470099993 cites W2014251969 @default.
• W2470099993 cites W2016301107 @default.
• W2470099993 cites W2017451097 @default.
• W2470099993 cites W2022950108 @default.
• W2470099993 cites W2024724654 @default.
• W2470099993 cites W2030408049 @default.
• W2470099993 cites W2033775272 @default.
• W2470099993 cites W2039616579 @default.
• W2470099993 cites W2043040445 @default.
• W2470099993 cites W2043538870 @default.
• W2470099993 cites W2043667201 @default.
• W2470099993 cites W2045454247 @default.
• W2470099993 cites W2045908562 @default.
• W2470099993 cites W2048678124 @default.
• W2470099993 cites W2052052955 @default.
• W2470099993 cites W2054531769 @default.
• W2470099993 cites W2062145087 @default.
• W2470099993 cites W2062689482 @default.
• W2470099993 cites W2068813299 @default.
• W2470099993 cites W2070058303 @default.
• W2470099993 cites W2070889802 @default.
• W2470099993 cites W2075579265 @default.
• W2470099993 cites W2081547837 @default.
• W2470099993 cites W2085343242 @default.
• W2470099993 cites W2086912092 @default.
• W2470099993 cites W2087396792 @default.
• W2470099993 cites W2087561606 @default.
• W2470099993 cites W2088267142 @default.
• W2470099993 cites W2091466360 @default.
• W2470099993 cites W2099913359 @default.
• W2470099993 cites W2108177844 @default.
• W2470099993 cites W2126243275 @default.
• W2470099993 cites W2126544114 @default.
• W2470099993 cites W2138393164 @default.
• W2470099993 cites W2138613751 @default.
• W2470099993 cites W2141907076 @default.
• W2470099993 cites W2164531086 @default.
• W2470099993 cites W2168898378 @default.
• W2470099993 cites W2170248514 @default.
• W2470099993 cites W2216827809 @default.
• W2470099993 cites W2315723477 @default.
• W2470099993 cites W2470938080 @default.
• W2470099993 cites W2532585990 @default.
• W2470099993 cites W4236412125 @default.
• W2470099993 cites W4253564807 @default.
• W2470099993 cites W758260955 @default.
• W2470099993 doi "https://doi.org/10.1016/j.cbi.2016.07.008" @default.
• W2470099993 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27417252" @default.
• W2470099993 hasPublicationYear "2016" @default.
• W2470099993 type Work @default.
• W2470099993 sameAs 2470099993 @default.
• W2470099993 citedByCount "25" @default.
• W2470099993 countsByYear W24700999932017 @default.
• W2470099993 countsByYear W24700999932018 @default.
• W2470099993 countsByYear W24700999932019 @default.
• W2470099993 countsByYear W24700999932020 @default.
• W2470099993 countsByYear W24700999932021 @default.
• W2470099993 countsByYear W24700999932022 @default.
• W2470099993 countsByYear W24700999932023 @default.
• W2470099993 crossrefType "journal-article" @default.
• W2470099993 hasAuthorship W2470099993A5007615482 @default.
• W2470099993 hasAuthorship W2470099993A5008074177 @default.
• W2470099993 hasAuthorship W2470099993A5015424874 @default.
• W2470099993 hasAuthorship W2470099993A5023842343 @default.
• W2470099993 hasAuthorship W2470099993A5045918329 @default.
• W2470099993 hasAuthorship W2470099993A5048990516 @default.
• W2470099993 hasAuthorship W2470099993A5049966177 @default.
• W2470099993 hasAuthorship W2470099993A5066182280 @default.
• W2470099993 hasAuthorship W2470099993A5066258586 @default.
• W2470099993 hasAuthorship W2470099993A5068621397 @default.

• next